BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1292471)

  • 41. Common subunits of cytokine receptors and the functional redundancy of cytokines.
    Miyajima A; Hara T; Kitamura T
    Trends Biochem Sci; 1992 Oct; 17(10):378-82. PubMed ID: 1455505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The biological activities of interleukin-1.
    Fibbe WE; Schaafsma MR; Falkenburg JH; Willemze R
    Blut; 1989 Aug; 59(2):147-56. PubMed ID: 2527574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-6 and its receptor: a paradigm for cytokines.
    Kishimoto T; Akira S; Taga T
    Science; 1992 Oct; 258(5082):593-7. PubMed ID: 1411569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human interleukin-9: a new cytokine in hematopoiesis.
    Yang YC
    Leuk Lymphoma; 1992 Dec; 8(6):441-7. PubMed ID: 1297478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interleukin-11/receptor complex: rational design of agonists/antagonists and immunoassays potentially useful in human therapy.
    Jacques Y; Minvielle S; Müller-Newen G; Heinrich PC; Grötzinger J; Montero-Julian F; Brailly H; Wilkin JM; Content J
    Res Immunol; 1998; 149(7-8):737-40. PubMed ID: 9851534
    [No Abstract]   [Full Text] [Related]  

  • 46. Interleukin-1 signal transduction.
    Bankers-Fulbright JL; Kalli KR; McKean DJ
    Life Sci; 1996; 59(2):61-83. PubMed ID: 8699924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of the carboxy-terminus of human interleukin-11 in conserving its biological activity.
    Miyadai K; Ohsumi J; Yoshimura C; Kawashima I; Ito Y
    Biosci Biotechnol Biochem; 1996 Mar; 60(3):541-2. PubMed ID: 8901120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-9.
    Renauld JC; Houssiau F; Louahed J; Vink A; Van Snick J; Uyttenhove C
    Adv Immunol; 1993; 54():79-97. PubMed ID: 8379467
    [No Abstract]   [Full Text] [Related]  

  • 49. Interleukin 11: an overview.
    Yang YC
    Stem Cells; 1993 Nov; 11(6):474-86. PubMed ID: 8111307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-11 in Pathologies of the Nervous System.
    Airapetov MI; Eresko SO; Ignatova PD; Lebedev AA; Bychkov ER; Shabanov PD
    Mol Biol; 2023; 57(1):1-6. PubMed ID: 37016665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway.
    Ng B; Cook SA; Schafer S
    Exp Mol Med; 2020 Dec; 52(12):1871-1878. PubMed ID: 33262481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of interleukin-11 on the expression of human bone sialoprotein gene.
    Matsumura H; Nakayama Y; Takai H; Ogata Y
    J Bone Miner Metab; 2015 Mar; 33(2):142-53. PubMed ID: 24633490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.
    Nahid P; Bliven-Sizemore E; Jarlsberg LG; De Groote MA; Johnson JL; Muzanyi G; Engle M; Weiner M; Janjic N; Sterling DG; Ochsner UA
    Tuberculosis (Edinb); 2014 May; 94(3):187-96. PubMed ID: 24629635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of cytokine signaling during nervous system development.
    Mousa A; Bakhiet M
    Int J Mol Sci; 2013 Jul; 14(7):13931-57. PubMed ID: 23880850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth.
    Nieminen P; Morgan NV; Fenwick AL; Parmanen S; Veistinen L; Mikkola ML; van der Spek PJ; Giraud A; Judd L; Arte S; Brueton LA; Wall SA; Mathijssen IM; Maher ER; Wilkie AO; Kreiborg S; Thesleff I
    Am J Hum Genet; 2011 Jul; 89(1):67-81. PubMed ID: 21741611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.
    Mitsuyama K; Tomiyasu N; Suzuki A; Takaki K; Takedatsu H; Masuda J; Yamasaki H; Matsumoto S; Tsuruta O; Toyonaga A; Sata M
    Clin Exp Immunol; 2006 Jan; 143(1):125-31. PubMed ID: 16367943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metallothionein induction in cultured rat hepatocytes by arthritic rat serum, activated macrophages, interleukin-6, interleukin-11 and leukaemia inhibitory factor.
    Coyle P; Philcox JC; Rofe AM
    Inflamm Res; 1995 Nov; 44(11):475-81. PubMed ID: 8597881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
    Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
    J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acid-catalyzed peptide bond hydrolysis of recombinant human interleukin 11.
    Kenley RA; Warne NW
    Pharm Res; 1994 Jan; 11(1):72-6. PubMed ID: 8140058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.